Nursing Research and Practice / 2012 / Article / Tab 2

Research Article

“Keeping the Boogie Man Away”: Medication Self-Management among Women Receiving Anastrozole Therapy

Table 2

The women’s self-reported side effects.

IDHot flashesArthralgiasSleep disturbanceFatigueWeight gain or lossAnxiety/depressive symptoms“Female things”Cognitive problems

1BBothIBBDI-II, PB
2BothIBBDI-II, PBothBoth
3*BothBBDI-II, P, IBCPTI
4BothIBBDI-II, PBothB
5BBothBDI-II, PB
6BothBIBDI-II, PBB
7BothBBBDI-II, PBB
8BothBIIBothBDI-II, PBoth
9BothBIIBBDI-II, PB
10BothBothIBDI-II, PBB
11BBothBBDI-II, PBB
12BothBothIIBDI-II, PBoth

Arthralgias were defined as aches, pains, and joint pains. “Female things” were defined as vaginal itching, vaginal bleeding, vaginal discharge, or pain with intercourse.
B: Symptoms reported by the participant on the Breast Cancer Prevention Trial (BCPT) Symptom Checklist only.
I: Symptoms reported by the participant during the interview only.
Both: Symptoms reported by the participant in both the interview and the BCPT.
P: Anxiety reported by the participant in the Profile of Mood States (POMS) Tension-Anxiety Subscale.
BDI-II: Depressive symptoms reported by the participant in the Beck Depression Inventory-II Scale.
*This participant was the only woman to specifically express depressive symptoms or anxiety in her interview.